Curanex Pharmaceuticals Inc (CURX) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$4.40

From 52W high−18.67%

Volume21288.00

Market cap$6.90M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataSep 18, 2026

Open

$4.40

From 52W high

−18.67%

Volume

21288.00

Market cap

$6.90M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.4x

P/E (TTM)

—

RSI (14)

58.1

MomentumView details →

1D Return

−4.35%

YTD Return

+1300.48%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−0.4x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

1.4x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−218.65%

ROA (TTM)

−206.32%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

−4.35%

YTD Return

+1300.48%

1Y Return

+289.08%

RSI (14)

58.1

vs 50D SMA

+49.09%

vs 200D SMA

+339.32%

Capital & dividendView details →

Debt/Equity

0.06x

Current Ratio

45.95x

Quick Ratio

45.95x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.03

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−10.47M

Op. CF (TTM)

−12.08M

Latest newsMore news →

No recent news for CURX.

Similar companies

Bolt Biotherapeutics, Inc.BOLT Lexaria Bioscience Corp.LEXX AlphaTON Capital Corp.ALP Enveric Biosciences, Inc.ENVB Xenetic Biosciences, Inc.XBIO CNS Pharmaceuticals, Inc.CNSP Find similar companies →

Latest newsMore news →

No recent news for CURX.